Blog Bile Duct Cancer and Treatments Posted by Aprazer Healthcare July 30, 2025 0 Bile Duct Cancer Has a Very Low Survival Rate Bile duct cancer remains undiagno... Continue reading
Blog Aprazer Stands as Top Anticancer Medicine Manufacturer and Exporter Posted by Aprazer Healthcare July 29, 2025 0 Aprazer, involved in the development and launch of innovative oncology treatment... Continue reading
18 Jul Blog Aprazer Healthcare – Oncology Injection Manufacturer and Exporter Posted by Aprazer Healthcare July 26, 2025 0 Aprazer Healthcare leads the way in the fight against cancer, combining scientif... Continue reading
16 Jul Blog Can Hepatitis Be Considered the Leading Cause of Liver Cancer? Posted by Aprazer Healthcare July 16, 2025 0 The rising cases of liver cancer form a major health concern. However, there are... Continue reading
14 Jul Blog Chronic Liver Inflammation and the Risk of Liver Cancer Posted by Aprazer Healthcare July 16, 2025 0 Inflammation that persists in the liver cells for a long time tends to severely ... Continue reading
02 Jul Blog Enzalutamide (Indenza) in Castration-resistant Prostate Cancer Posted by Aprazer Healthcare July 11, 2025 0 Proven Effective in Multiple Stages of Disease Progression Prostate Cancer? Th... Continue reading
18 Jun Blog Know the Cancer Type and Its Treatment – Breast Cancer Posted by Aprazer Healthcare July 11, 2025 Hormone cancer is a highly prevalent cancer that constitutes about 60 percent of... Continue reading
13 Jun Blog Understanding the Hidden Nature of Kidney Cancer Posted by Aprazer Healthcare July 11, 2025 A small mass over the left kidney remained silent until it was incidentally disc... Continue reading
12 Jun Blog Turn the Tide against Hepatitis C – Powered by Aprazer’s Innovation and Care Posted by Aprazer Healthcare June 20, 2025 Hepatitis C silently kills a million lives every year. Aprazer Healthcare stand... Continue reading
11 Jun Blog Can a Benign Tumor Progress to Malignant? Posted by Aprazer Healthcare June 19, 2025 Often heard, the tumor for years was silent, and turns malignant. A benign tumo... Continue reading